These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29659739)

  • 1. Physical Exercise Improves Aging-Related Changes in Angiotensin, IGF-1, SIRT1, SIRT3, and VEGF in the Substantia Nigra.
    Muñoz A; Corrêa CL; Lopez-Lopez A; Costa-Besada MA; Diaz-Ruiz C; Labandeira-Garcia JL
    J Gerontol A Biol Sci Med Sci; 2018 Nov; 73(12):1594-1601. PubMed ID: 29659739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, Which Induces Vulnerability to Oxidative Stress and Neurodegeneration.
    Diaz-Ruiz C; Villar-Cheda B; Dominguez-Meijide A; Garrido-Gil P; Guerra MJ; Labandeira-Garcia JL
    J Gerontol A Biol Sci Med Sci; 2020 Feb; 75(3):416-424. PubMed ID: 30412227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans.
    Costa-Besada MA; Valenzuela R; Garrido-Gil P; Villar-Cheda B; Parga JA; Lanciego JL; Labandeira-Garcia JL
    Mol Neurobiol; 2018 Jul; 55(7):5847-5867. PubMed ID: 29086247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration.
    Diaz-Ruiz C; Rodriguez-Perez AI; Beiroa D; Rodriguez-Pallares J; Labandeira-Garcia JL
    Oncotarget; 2015 Sep; 6(29):26675-89. PubMed ID: 26384348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra. Implications for Parkinson's disease.
    Villar-Cheda B; Sousa-Ribeiro D; Rodriguez-Pallares J; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    J Cereb Blood Flow Metab; 2009 Feb; 29(2):230-4. PubMed ID: 18957989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration.
    Valenzuela R; Costa-Besada MA; Iglesias-Gonzalez J; Perez-Costas E; Villar-Cheda B; Garrido-Gil P; Melendez-Ferro M; Soto-Otero R; Lanciego JL; Henrion D; Franco R; Labandeira-Garcia JL
    Cell Death Dis; 2016 Oct; 7(10):e2427. PubMed ID: 27763643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system.
    Villar-Cheda B; Costa-Besada MA; Valenzuela R; Perez-Costas E; Melendez-Ferro M; Labandeira-Garcia JL
    Cell Death Dis; 2017 Sep; 8(9):e3044. PubMed ID: 28880266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.
    Rodriguez-Perez AI; Borrajo A; Diaz-Ruiz C; Garrido-Gil P; Labandeira-Garcia JL
    Oncotarget; 2016 May; 7(21):30049-67. PubMed ID: 27167199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration.
    Villar-Cheda B; Valenzuela R; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Aging; 2012 Jan; 33(1):204.e1-11. PubMed ID: 20888078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging-related dysregulation of dopamine and angiotensin receptor interaction.
    Villar-Cheda B; Dominguez-Meijide A; Valenzuela R; Granado N; Moratalla R; Labandeira-Garcia JL
    Neurobiol Aging; 2014 Jul; 35(7):1726-38. PubMed ID: 24529758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the brain renin-angiotensin system in Parkinson´s disease.
    Labandeira-Garcia JL; Labandeira CM; Guerra MJ; Rodriguez-Perez AI
    Transl Neurodegener; 2024 Apr; 13(1):22. PubMed ID: 38622720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system.
    Kim EN; Kim MY; Lim JH; Kim Y; Shin SJ; Park CW; Kim YS; Chang YS; Yoon HE; Choi BS
    Atherosclerosis; 2018 Mar; 270():123-131. PubMed ID: 29407880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined exercise and insulin-like growth factor-1 supplementation induces neurogenesis in old rats, but do not attenuate age-associated DNA damage.
    Koltai E; Zhao Z; Lacza Z; Cselenyak A; Vacz G; Nyakas C; Boldogh I; Ichinoseki-Sekine N; Radak Z
    Rejuvenation Res; 2011 Dec; 14(6):585-96. PubMed ID: 21867412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra.
    Rodriguez-Perez AI; Garrido-Gil P; Pedrosa MA; Garcia-Garrote M; Valenzuela R; Navarro G; Franco R; Labandeira-Garcia JL
    Brain Behav Immun; 2020 Jul; 87():256-271. PubMed ID: 31863823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism.
    Gleave JA; Arathoon LR; Trinh D; Lizal KE; Giguère N; Barber JHM; Najarali Z; Khan MH; Thiele SL; Semmen MS; Koprich JB; Brotchie JM; Eubanks JH; Trudeau LE; Nash JE
    Neurobiol Dis; 2017 Oct; 106():133-146. PubMed ID: 28673739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the
    Quijano A; Diaz-Ruiz C; Lopez-Lopez A; Villar-Cheda B; Muñoz A; Rodriguez-Perez AI; Labandeira-Garcia JL
    Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II and 1-7 during aging in Metabolic Syndrome rats. Expression of AT1, AT2 and Mas receptors in abdominal white adipose tissue.
    Rubio-Ruíz ME; Del Valle-Mondragón L; Castrejón-Tellez V; Carreón-Torres E; Díaz-Díaz E; Guarner-Lans V
    Peptides; 2014 Jul; 57():101-8. PubMed ID: 24819472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β.
    Muñoz A; Garrido-Gil P; Dominguez-Meijide A; Labandeira-Garcia JL
    Exp Neurol; 2014 Nov; 261():720-32. PubMed ID: 25160895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease.
    Villar-Cheda B; Rodríguez-Pallares J; Valenzuela R; Muñoz A; Guerra MJ; Baltatu OC; Labandeira-Garcia JL
    Eur J Neurosci; 2010 Nov; 32(10):1695-706. PubMed ID: 20964730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise induces renin-angiotensin system unbalance and high collagen expression in the heart of Mas-deficient mice.
    Guimarães GG; Santos SH; Oliveira ML; Pimenta-Velloso EP; Motta DF; Martins AS; Alenina N; Bader M; Santos RA; Campagnole-Santos MJ
    Peptides; 2012 Nov; 38(1):54-61. PubMed ID: 22921883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.